Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pellets Pharma is a specialized pharmaceutical company based in Hyderabad, India, that focuses on the development and manufacture of pharmaceutical pellets using advanced drug delivery systems. The company specializes in multi-particulate dosage forms, including sustained-release, delayed-release, and timed-release pellets. Their core product portfolio features a wide range of generic active pharmaceutical ingredients in pellet form, such as omeprazole, lansoprazole, and itraconazole. Pellets Pharma serves as a Contract Development and Manufacturing Organization (CDMO) for global pharmaceutical companies, leveraging its WHO-GMP certified facilities. The company's expertise lies in pelletization technologies like extrusion-spheronization and fluid bed coating. They export their products to various regulated and semi-regulated markets worldwide, providing customized formulation solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pellets Pharma.